Heudobler, Daniel and Herr, Wolfgang and Thomas, Simone (2019) Immunotherapies in hematology and oncology. ONKOLOGE, 25. pp. 77-82. ISSN 0947-8965, 1433-0415
Full text not available from this repository. (Request a copy)Abstract
Background Modern immuno-oncology has revolutionized cancer therapy in recent years. Objective This article provides an overview of current treatment options. Material and methods Review of the current study situation. Results In oncology immune checkpoint inhibitors (ICPi) in monotherapy or also in combination with other drugs have become the standard of care in many tumor entities. In the treatment of hematological neoplasms chimeric antigen receptor (CAR) T-cells and bispecific antibodies have shown impressive response rates. Tumor vaccination represents another treatment option with high potential, but has not yet achieved broad clinical application. Conclusion Immuno-oncology with diverse approaches has become the current standard of care in cancer treatment.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | IPILIMUMAB; NIVOLUMAB; CHEMOTHERAPY; THERAPY; CANCER; Immuno-oncology; Immune checkpoint; TCR; CAR T-cell therapy; Bispecific antibodies; Vaccination |
| Subjects: | 600 Technology > 610 Medical sciences Medicine |
| Divisions: | Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie) |
| Depositing User: | Dr. Gernot Deinzer |
| Date Deposited: | 31 Mar 2020 06:13 |
| Last Modified: | 31 Mar 2020 06:13 |
| URI: | https://pred.uni-regensburg.de/id/eprint/26339 |
Actions (login required)
 |
View Item |
